The Power of RNA in Detecting Gene Fusions for Cancer Diagnostics
Christopher McGee, MSc
RNA profiling provides an effective and accurate method of gene fusion detection for clinical oncology diagnostics
Christopher McGee, MSc
Chris McGee, MSc, is a senior scientist in the diagnostic products R&D group at PerkinElmer’s Horizon Discovery. Chris has contributed to the development of a range of RNA- and DNA-based genetic reference standards focused primarily on oncology next-generation sequencing (NGS).
Recently, Chris led the development of Horizon’s latest Pan-Cancer 6-Fusion RNA control. Prior to joining Horizon, Chris worked at the Wellcome Trust Sanger Institute in Cambridge (UK) and the University of Galway.